KẾT QUẢ PHẪU THUẬT NỘI SOI QUA TIỀN ĐÌNH MIỆNG ĐIỀU TRỊ VI UNG THƯ TUYẾN GIÁP THỂ NHÚ TẠI BỆNH VIỆN K

Abstract

Objectives: This study was conducted to report clinicals, subclinicals and evaluate the results of TOETVA in management of papillary thyroid microcarcinoma. Patients and methods: From 1/2020-12/2021, we performed 98 transoral endoscopic thyroidectomies vi a the vestibular approach for papillary thyroid microcarcinoma. Clinical features and outcomes were analyzed from both retrospectively and prospectively maintained database. Results: The average age was 33.4 ± 6.94 years, male/female ratio is 1/97. The average tumor size was 5.3 ± 1.95 mm . 89.9% patients underwent hemithyroidectomy, ismuthectomy plus unilateral central neck dissection with 93.5 ± 15.7 minutes for the mean operative time. While 10.1% patients had total thyroidectomy plus bilateral central neck dissection with 124.5 ± 22.16 minutes for the mean operative time. The rate of complications was very low. All patients were highly satisfied with the surgical outcome, especially, cosmetic results.. Conclusion: The TOETVA for treating papillary thyroid microcarcinoma is a safe and effective procedure.